Background: Ommaya reservoirs are ventricular access devices used for chemotherapeutic treatment of hematological malignancies with CNS involvement. We report a case describing inadvertent intra-parenchymal spread of chemotherapy resulting from unrecognized failed access of the device. Presentation: A 56 year old male had an Ommaya reservoir placed for relapsed monoclonal acute myeloid leukemia with CNS involvement. Routine post-operative CT was unremarkable and demonstrated satisfactory device placement. After the device was accessed and utilized, subsequent CT disclosed new moderate sized intra-parenchymal hemorrhage centered on the Ommaya catheter with significant scalp hematoma. Fluoroscopic ventriculogram demonstrated faulty access with contrast filling around the reservoir and tracking through the burr holes into brain parenchyma. Reaccessing the device correctly showed a patent system without extravasations and normal drainage into ventricular CSF pathways. Conclusions: Adequate training and supervision is necessary for accessing ventricular reservoirs to prevent local extravasation. This case illustrates that extravasation may extend through the burr hole to affect adjacent brain parenchyma, falsely simulating a detached catheter. Fluoroscopic ventriculograms are useful in diagnosing problems with intraventricular catheters and in this case the patency of the Ommaya reservoir system was demonstrated, allowing its ongoing use after correct cannulation.
[1]
S. Taillibert,et al.
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients
,
2015,
Journal of Neuro-Oncology.
[2]
I. Slavc,et al.
Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients
,
2014,
Journal of Neuro-Oncology.
[3]
M. Glantz,et al.
Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis
,
2010,
Cancer.
[4]
P. Scheltens,et al.
Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device
,
1993,
Journal of Neuro-Oncology.
[5]
W. Shapiro,et al.
Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
,
1975,
The New England journal of medicine.